Stephen J. Schuster, MD
Hematology

Stephen J. Schuster, MD

Hematology
Sees patients age 15 through 65
Abramson Cancer Center Perelman 4th Floor West
Penn Medicine Provider

About me

  • Director, Lymphoma Program
  • Director, Lymphoma Translational Research
  • Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research

My education and training

  • Thomas Jefferson UniversityMedical School
  • Pennsylvania HospitalResidency
  • Thomas Jefferson University HospitalFellowship
  • Pennsylvania HospitalFellowship
Watch video featuring Stephen J. Schuster, MD on YouTube

Spoken languages

English
English

Reviews

Average Rating

839 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Dr. Schuster is good.
Anonymous
September 2026
Is just that I felt very good about everything, even being almost on time
Anonymous
September 2026
They take their time and are very personable
Anonymous
September 2026
The best

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Schuster is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Wudhikarn, Kitsada. Bromberg, Maria. Brower, Jamie. Seshan, Venkatraman. Bachanova, Veronika. Ahmed, Sairah. McGuirk, Joseph P. Manu, Gurusidda. Maziarz, Richard T. Oluwole, Olalekan O. Schuster, Stephen J. Porter, David L. Bishop, Michael R. Riedell, Peter A. Perales, Miguel-Angel. Dahi, Parastoo B. Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. , Blood Adv., 10(18): 2026,6188-6197


Paruzzo, Luca. Chong, Emeline R. Chong, Elise A. Zheng, Zhixuan. Guruprasad, Puneeth. Landsburg, Daniel J. Nasta, Sunita D. Stella, Federico. Ramasubramanian, Ranjani. de Souza, Vitor B. Alkhatib, Mohannad H. Ho, Matthew. Imparato, Antonio. Chen, Gregory M. Siegel, Don L. Plesa, Gabriela. Dai, Anlan. Mackey, Shane. Das, Priyamvada. Michener, Peter. Jadlowsky, Julie. Bushman, Frederic D. Patel, Vrutti. Carturan, Alberto. Napier, Ellen B. Gonzalez, Vanessa E. Jarocha, Danuta. Xu, Rong. Levine, Bruce L. Porazzi, Patrizia. Frey, Noelle. Porter, David L. Svoboda, Jakub. Fraietta, Joseph A. June, Carl H. Schuster, Stephen J. Ruella, Marco. Decade-long persistence of CD19 CAR T cells in B cell lymphomas. , Nat Med., 32(9): 2026,3276-3287


Noll, Julia Han. Dersh, Devin. Li, Jiang Yuan. Hemani, Humza. Lavorando, Maya. Bartoszek, Robert. Amses, Kevin R. Jain, Ankita. Minehart, Janna. Ho, Matthew. Ramirez-Fernandez, Angel. Paruzzo, Luca. Shestov, Max A. Camerini, Elena. Peters, Fleur S. Huang, Xiao. Loren, Alison W. Woyach, Jennifer A. Goronzy, Jorg Josef. Kater, Arnon P. Ruella, Marco. Byrd, John C. Powell, Daniel J., Jr. Gill, Saar I. Porter, David L. Schuster, Stephen J. Bushman, Frederic D. Siegel, Donald L. Levine, Bruce L. June, Carl H. Frey, Noelle V. Cohen, Adam D. Garfall, Alfred L. Long, Meixiao. Maus, Marcela V. Weng, Nan-Ping. Diorio, Caroline. Fraietta, Joseph A. T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia. , Blood.: 2026


Woyach, Jennifer A. Popovic, Relja. Rossi, Emily L. Singh, Sanjana. Oki, Toshihiko. Rosenberg, Tanya S. Qian, Chen. Moran, Michael. Liu, Zihuan. Boyer, Michelle. Jones, Jeffrey. Furman, Richard R. Wierda, William. Gotlib, Jason. Schuster, Stephen J. Chyla, Brenda. Davids, Matthew S. Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up. , Am J Hematol., 101(7): 2026,1516-1521


Ma, Nian. Bose, Dipayan. Svoboda, Jakob. Chong, Elise A. Schuster, Stephen J. Robertson, Erle S. FGFR2 is an oncogenic driver critical for successful human gammaherpesvirus latent infection and oncogenesis. , Proc Natl Acad Sci USA., 123(30): 2026


Wierda, William G. Dorritie, Kathleen A. Gauthier, Jordan. Nath, Rajneesh. Kipps, Thomas J. Riedell, Peter A. Eradat, Herbert A. Kenderian, Saad S. Kharfan-Dabaja, Mohamed A. Shah, Nirav N. Solomon, Scott R. Stephens, Deborah M. Ermann, Daniel A. Arnason, Jon E. Deol, Abhinav. Feldman, Tatyana A. Babis Andreadis, Charalambos. Ghosh, Monalisa. Ma, Shuo. Schuster, Stephen J. Gergis, Usama. Vose, Julie M. Soumerai, Jacob D. van Besien, Koen. Tuazon, Sherilyn A. Perna, Serena K. Ou, San-San. Ananthakrishnan, Revathi. Rane, Neha. Papp, Eniko. Ansari, Sahar. Thompson, Ethan G. Okal, Abood. Peiser, Leanne. Chen, Yizhe. Sengupta, Sanhita. Ray, Pradipta Ranjan. Wang, Jixian. Siddiqi, Tanya. Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004. , Blood.: 2026


Baron, Jonathan A. Chelius, Monica. Singh, Gurbani. Schad, Michael D. Berger, Melanie. Chong, Emeline R. Thomas, Colin J. Carter, Jordan S. Cook, Michael R. Nasta, Sunita D. Landsburg, Daniel J. Barta, Stefan K. Svoboda, Jakub. Schuster, Stephen J. Yegya-Raman, Nikhil. LaRiviere, Michael J. Plastaras, John P. Chong, Elise A. Hubbeling, Harper. Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas. , Clin Lymphoma Myeloma Leuk.: 2026


Ruella, Marco. Paruzzo, Luca. Chong, Emeline R. Chong, Elise A. Landsburg, Daniel J. Nasta, Sunita D. Devi, Pooja. Michener, Peter. Stella, Federico. Carturan, Alberto. Napier, Ellen B. Van Deerlin, Vivianna M. Porazzi, Patrizia. Levine, Bruce L. Frey, Noelle. Porter, David L. Fraietta, Joseph A. Svoboda, Jakub. June, Carl H. Schuster, Stephen J. Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas. , N Engl J Med., 394(24): 2026,2440-2448


Bartlett, Nancy L. Sehn, Laurie H. Assouline, Sarit. Giri, Pratyush. Kuruvilla, John. Schuster, Stephen J. Yoon, Sung-Soo. Fay, Keith. Hess, Georg. Dreyling, Martin. Gutierrez, Norma C. Cybulski, Eva. Sabalvaro, Fidelis. Penuel, Elicia. Teodoro, Vanda. Tracy, Samuel. Kuruvilla, Denison. Chen, Joseph. Wiebking, Volker. Wei, Michael C. Budde, L Elizabeth. Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis. , Am J Hematol., 101(5): 2026,986-997


Schneider, Michael. Paruzzo, Luca. Stella, Federico. Noll, Julia Han. Ho, Matthew. Babatunde, Victor. Ho, Bianca. Devi, Pooja. Chong, Elise A. Barta, Stefan K. Nasta, Sunita D. Svoboda, Jakub. Carter, Jordan. Cook, Michael R. Hossain, Nasheed M. Thomas, Colin J. Patel, Vrutti. de Souza, Vitor B. Alkhatib, Mohannad H. Li, Ziyu. Tan, Melody. Michener, Peter. Guruprasad, Puneeth. Imparato, Antonio. Carturan, Alberto. Porazzi, Patrizia. Fraietta, Joseph A. Schuster, Stephen J. Maillard, Ivan. Ruella, Marco. Landsburg, Daniel J. Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy. , Nat Commun., 17(1): 2026,6486


View all publications